Viewing StudyNCT04655599



Ignite Creation Date: 2024-05-06 @ 3:30 PM
Last Modification Date: 2024-10-26 @ 1:51 PM
Study NCT ID: NCT04655599
Status: TERMINATED
Last Update Posted: 2021-05-17
First Post: 2020-11-19

Brief Title: Effect of Olorinab on Gastrointestinal Transit in Patients With Irritable Bowel Syndrome
Sponsor: Arena Pharmaceuticals
Organization: Arena Pharmaceuticals

Conditions & Keywords Data

Conditions:
Name
Irritable Bowel Syndrome
Keywords:
Name View
IBS-D View
Olorinab View
APD371 View
Irritable bowel syndrome View
IBS View
IBS with predominant constipation View
IBS-C View
IBS with predominant diarrhea View